Results 71 to 80 of about 229,005 (218)

Vasopressin inhibits mitogen-activated protein kinases and activated protein-1 in macrophages

open access: yesActa Anaesthesiologica Taiwanica, 2015
We have previously shown that vasopressin could inhibit the upregulation of inflammatory mediators. Expression of inflammatory mediators is tightly regulated by the upstream transcriptional pathway mitogen-activated protein kinases (MAPKs) and activated protein-1 (AP-1). In this study, we elucidated whether vasopressin could inhibit the upregulation of
Chen, Yu-Long   +3 more
openaire   +2 more sources

In Silico Design of E3 Ubiquitin-Protein Ligase NEDD4-1 Inhibitors: An Alternative Approach for Targeting the MAPK Pathway in Cancer Therapy

open access: yesProceedings, 2019
Among all the several targets in common use in the antitumor therapies, the pharmacologicinhibition of the MAPK (Mitogen Activated Protein Kinase) pathway represents an efficienttherapeutic approach [1]. [...]
Davide Pirolli   +5 more
doaj   +1 more source

Cetylpyridinium chloride triggers paraptosis to suppress pancreatic tumor growth via the ERN1-MAP3K5-p38 pathway

open access: yesiScience
Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive solid malignancy with low 5-year survival and limited treatment options. We conducted an unbiased screening using FDA-approved drug and demonstrated that cetylpyridinium chloride ...
Hu Tang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy